메뉴 건너뛰기
Journal of Clinical Oncology
Volumn 32, Issue 36, 2014, Pages 4033-4034
Markers for the early detection of prostate cancer: Some principles for statistical reporting and interpretation
Author keywords

[No Author keywords available]
Indexed keywords

PROSTATE CANCER ANTIGEN 3, HUMAN; PROSTATE SPECIFIC ANTIGEN; TUMOR ANTIGEN;
EID: 84919933492     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2014.58.5547     Document Type: Editorial
Times cited : (9)
References (8)
  • 1
    • 84916237853 scopus 로고    scopus 로고
    • Can urinary PCA3 supplement PSA in the early detection of prostate cancer?
    • Wei JT, Feng Z, Partin AW, et al: Can urinary PCA3 supplement PSA in the early detection of prostate cancer? J Clin Oncol 32:4066-4072, 2014
    • (2014) J Clin Oncol , vol.32 , pp. 4066-4072
    • Wei, J.T.1    Feng, Z.2    Partin, A.W.3
  • 2
    • 42149185603 scopus 로고    scopus 로고
    • Systematic review of statistical methods used in molecular marker studies in cancer
    • Vickers AJ, Jang K, Sargent D, et al: Systematic review of statistical methods used in molecular marker studies in cancer. Cancer 112:1862-1868, 2008
    • (2008) Cancer , vol.112 , pp. 1862-1868
    • Vickers, A.J.1    Jang, K.2    Sargent, D.3
  • 3
    • 84901400634 scopus 로고    scopus 로고
    • Diagnostic ability of %p2PSA and prostate health index for aggressive prostate cancer: A meta-analysis
    • Wang W, Wang M, Wang L, et al: Diagnostic ability of %p2PSA and prostate health index for aggressive prostate cancer: A meta-analysis. Sci Rep 4:5012, 2014
    • (2014) Sci Rep , vol.4 , pp. 5012
    • Wang, W.1    Wang, M.2    Wang, L.3
  • 4
    • 17844402699 scopus 로고    scopus 로고
    • 20-year outcomes following conservative management of clinically localized prostate cancer
    • Albertsen PC, Hanley JA, Fine J: 20-year outcomes following conservative management of clinically localized prostate cancer. JAMA 293:2095-2101, 2005
    • (2005) JAMA , vol.293 , pp. 2095-2101
    • Albertsen, P.C.1    Hanley, J.A.2    Fine, J.3
  • 5
    • 84864008031 scopus 로고    scopus 로고
    • Radical prostatectomy versus observation for localized prostate cancer
    • Wilt TJ, Brawer MK, Jones KM, et al: Radical prostatectomy versus observation for localized prostate cancer. N Engl J Med 367:203-213, 2012
    • (2012) N Engl J Med , vol.367 , pp. 203-213
    • Wilt, T.J.1    Brawer, M.K.2    Jones, K.M.3
  • 6
    • 84862877628 scopus 로고    scopus 로고
    • Individualized estimation of the benefit of radical prostatectomy from the Scandinavian Prostate Cancer Group randomized trial
    • Vickers A, Bennette C, Steineck G, et al: Individualized estimation of the benefit of radical prostatectomy from the Scandinavian Prostate Cancer Group randomized trial. Eur Urol 62:204-209, 2012
    • (2012) Eur Urol , vol.62 , pp. 204-209
    • Vickers, A.1    Bennette, C.2    Steineck, G.3
  • 7
    • 84901398629 scopus 로고    scopus 로고
    • Prostate Cancer Prevention Trial risk calculator 2.0 for the prediction of low- vs high-grade prostate cancer
    • Ankerst DP, Hoefler J, Bock S, et al: Prostate Cancer Prevention Trial risk calculator 2.0 for the prediction of low- vs high-grade prostate cancer. Urology 83:1362-1367, 2014
    • (2014) Urology , vol.83 , pp. 1362-1367
    • Ankerst, D.P.1    Hoefler, J.2    Bock, S.3
  • 8
    • 84855475622 scopus 로고    scopus 로고
    • Assessing the incremental value of diagnostic and prognostic markers: A review and illustration
    • Steyerberg EW, Pencina MJ, Lingsma HF, et al: Assessing the incremental value of diagnostic and prognostic markers: A review and illustration. Eur J Clin Invest 42:216-228, 2012
    • (2012) Eur J Clin Invest , vol.42 , pp. 216-228
    • Steyerberg, E.W.1    Pencina, M.J.2    Lingsma, H.F.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.